Cargando…
Human Monoclonal Antibodies Broadly Neutralizing against Influenza B Virus
Influenza virus has the ability to evade host immune surveillance through rapid viral genetic drift and reassortment; therefore, it remains a continuous public health threat. The development of vaccines producing broadly reactive antibodies, as well as therapeutic strategies using human neutralizing...
Autores principales: | Yasugi, Mayo, Kubota-Koketsu, Ritsuko, Yamashita, Akifumi, Kawashita, Norihito, Du, Anariwa, Sasaki, Tadahiro, Nishimura, Mitsuhiro, Misaki, Ryo, Kuhara, Motoki, Boonsathorn, Naphatsawan, Fujiyama, Kazuhito, Okuno, Yoshinobu, Nakaya, Takaaki, Ikuta, Kazuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567173/ https://www.ncbi.nlm.nih.gov/pubmed/23408886 http://dx.doi.org/10.1371/journal.ppat.1003150 |
Ejemplares similares
-
Emerging Antigenic Variants at the Antigenic Site Sb in Pandemic A(H1N1)2009 Influenza Virus in Japan Detected by a Human Monoclonal Antibody
por: Yasugi, Mayo, et al.
Publicado: (2013) -
Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors
por: Kubota-Koketsu, Ritsuko, et al.
Publicado: (2009) -
Significant neutralizing activities against H2N2 influenza A viruses
in human intravenous immunoglobulin lots manufactured from 1993 to
2010
por: Kubota-Koketsu, Ritsuko, et al.
Publicado: (2012) -
Virus Neutralization by Human Intravenous Immunoglobulin Against Influenza Virus Subtypes A/H5 and A/H7
por: Kubota-Koketsu, Ritsuko, et al.
Publicado: (2021) -
Characterization of H5N1 Influenza Virus Variants with Hemagglutinin Mutations Isolated from Patients
por: Watanabe, Yohei, et al.
Publicado: (2015)